Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 11:13 PM
Ignite Modification Date:
2025-12-25 @ 8:49 PM
NCT ID:
NCT04704869
Group ID:
EG001
Title:
Early Cryoprecipitate + Massive Transfusion Protocol (RBCs, Plasma, Platelets, Whole Blood)
Description:
Cryoprecipitate will be given in addition to the standard of care massive transfusion protocol products, which include red blood cells, plasma, platelets and whole blood. The Cryoprecipitate will be given with 90 minutes of emergency department arrival. Cryoprecipitate dose will be 3 pools (equivalent to 15 single units).
Cryoprecipitate: Cryoprecipitate is a blood product high in fibrinogen. The Cryoprecipitate will be given with 90 minutes of emergency department arrival. Cryoprecipitate dose will be 3 pools (equivalent to 15 single units).
Red Blood Cells: RBCs are utilized as part of the Massive Transfusion protocol for hemorrhage control.
Plasma: Plasma is utilized as part of the Massive Transfusion protocol for hemorrhage control.
Platelets: Platelets are utilized as part of the Massive Transfusion protocol for hemorrhage control.
Whole Blood: Whole Blood is utilized as part of the Massive Transfusion protocol for hemorrhage control.
Deaths Number Affected:
192
Deaths Number At Risk:
None
Serious Number Affected:
84
Serious Number At Risk:
799
Other Number Affected:
0
Other Number At Risk:
799
Study:
NCT04704869
Results Section:
NCT04704869
Adverse Events Module:
NCT04704869